» Articles » PMID: 16513154

Evidence That Maturation of the N-linked Glycans of the Respiratory Syncytial Virus (RSV) Glycoproteins is Required for Virus-mediated Cell Fusion: The Effect of Alpha-mannosidase Inhibitors on RSV Infectivity

Overview
Journal Virology
Specialty Microbiology
Date 2006 Mar 4
PMID 16513154
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Glycan heterogeneity of the respiratory syncytial virus (RSV) fusion (F) protein was demonstrated by proteomics. The effect of maturation of the virus glycoproteins-associated glycans on virus infectivity was therefore examined using the alpha-mannosidase inhibitors deoxymannojirimycin (DMJ) and swainsonine (SW). In the presence of SW the N-linked glycans on the F protein appeared in a partially mature form, whereas in the presence of DMJ no maturation of the glycans was observed. Neither inhibitor had a significant effect on G protein processing or on the formation of progeny virus. Although the level of infectious virus and syncytia formation was not significantly affected by SW-treatment, DMJ-treatment correlated with a one hundred-fold reduction in virus infectivity. Our data suggest that glycan maturation of the RSV glycoproteins, in particular those on the F protein, is an important step in virus maturation and is required for virus infectivity.

Citing Articles

Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization.

Leemans A, Boeren M, Van der Gucht W, Pintelon I, Roose K, Schepens B Viruses. 2018; 10(8).

PMID: 30110893 PMC: 6115940. DOI: 10.3390/v10080426.


Functional Role of N-Linked Glycosylation in Pseudorabies Virus Glycoprotein gH.

Vallbracht M, Rehwaldt S, Klupp B, Mettenleiter T, Fuchs W J Virol. 2018; 92(9).

PMID: 29437979 PMC: 5899193. DOI: 10.1128/JVI.00084-18.


Detection of Nuclear Protein Profile Changes by Human Metapneumovirus M2-2 Protein Using Quantitative Differential Proteomics.

Ren Y, Choi E, Zhang K, Chen Y, Ye S, Deng X Vaccines (Basel). 2017; 5(4).

PMID: 29207503 PMC: 5748611. DOI: 10.3390/vaccines5040045.


In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor.

Radke L, Sandig G, Lubitz A, Schliesser U, von Horsten H, Blanchard V Bioengineering (Basel). 2017; 4(3).

PMID: 28952549 PMC: 5615316. DOI: 10.3390/bioengineering4030070.